Sampling variability of liver fibrosis in chronic hepatitis C
P Bedossa, D Dargère, V Paradis - Hepatology, 2003 - journals.lww.com
Fibrosis is a common endpoint of clinical trials in chronic hepatitis C, and liver biopsy
remains the gold standard for fibrosis evaluation. However, variability in the distribution of …
remains the gold standard for fibrosis evaluation. However, variability in the distribution of …
[HTML][HTML] Sampling variability of liver fibrosis in chronic hepatitis C
P Bedossa, D Dargère, V Paradis - natap.org
Fibrosis is a common endpoint of clinical trials in chronic hepatitis C, and liver biopsy
remains the gold standard for fibrosis evaluation. However, variability in the distribution of …
remains the gold standard for fibrosis evaluation. However, variability in the distribution of …
[引用][C] Sampling variability of liver fibrosis in chronic hepatitis C
P BEDOSSA - Hepatology, 2003 - cir.nii.ac.jp
[PDF][PDF] Sampling Variability of Liver Fibrosis in Chronic Hepatitis C
P Bedossa, D Dargere, V Paradis - HEPATOLOGY, 2003 - academia.edu
Fibrosis is a common endpoint of clinical trials in chronic hepatitis C, and liver biopsy
remains the gold standard for fibrosis evaluation. However, variability in the distribution of …
remains the gold standard for fibrosis evaluation. However, variability in the distribution of …
[PDF][PDF] Sampling variability of liver fibrosis in chronic hepatitis C
P Bedossa, D Dargère, V Paradis - Hepatology, 2003 - Wiley Online Library
Fibrosis is a common endpoint of clinical trials in chronic hepatitis C, and liver biopsy
remains the gold standard for fibrosis evaluation. However, variability in the distribution of …
remains the gold standard for fibrosis evaluation. However, variability in the distribution of …
Sampling variability of liver fibrosis in chronic hepatitis C
P Bedossa, D Dargère… - Hepatology (Baltimore …, 2003 - pubmed.ncbi.nlm.nih.gov
Fibrosis is a common endpoint of clinical trials in chronic hepatitis C, and liver biopsy
remains the gold standard for fibrosis evaluation. However, variability in the distribution of …
remains the gold standard for fibrosis evaluation. However, variability in the distribution of …
Sampling variability of liver fibrosis in chronic hepatitis C
P Bedossa, D Dargère, V Paradis - Hepatology, 2003 - infona.pl
Fibrosis is a common endpoint of clinical trials in chronic hepatitis C, and liver biopsy
remains the gold standard for fibrosis evaluation. However, variability in the distribution of …
remains the gold standard for fibrosis evaluation. However, variability in the distribution of …
[引用][C] SAMPLING VARIABILITY OF LIVER FIBROSIS IN CHRONIC HEPATITIS C
P BEDOSSA, D DARGERE, V PARADIS - 2003 - sid.ir
[引用][C] Sampling variability of liver fibrosis in chronic hepatitis C
P BEDOSSA, D DARGERE… - Hepatology (Baltimore …, 2003 - pascal-francis.inist.fr
Sampling variability of liver fibrosis in chronic hepatitis C CNRS Inist Pascal-Francis CNRS
Pascal and Francis Bibliographic Databases Simple search Advanced search Search by …
Pascal and Francis Bibliographic Databases Simple search Advanced search Search by …
Sampling variability of liver fibrosis in chronic hepatitis C.
P Bedossa, D Dargère, V Paradis - 2003 - cabidigitallibrary.org
Fibrosis is a common endpoint of clinical trials in chronic hepatitis C, and liver biopsy
remains the gold standard for fibrosis evaluation. However, variability in the distribution of …
remains the gold standard for fibrosis evaluation. However, variability in the distribution of …